Top

Published in:

Open Access 01-12-2021 | Stroke | Review

Ischemic Stroke and Sleep: The Linking Genetic Factors

Author: Lyudmila Korostovtseva

Published in: Cardiology and Therapy | Issue 2/2021

Abstract

This review summarizes the available data about genetic factors which can link ischemic stroke and sleep. Sleep patterns (subjective and objective measures) are characterized by heritability and comprise up to 38–46%. According to Mendelian randomization analysis, genetic liability for short sleep duration and frequent insomnia symptoms is associated with ischemic stroke (predominantly of large artery subtype). The potential genetic links include variants of circadian genes, genes encoding components of neurotransmitter systems, common cardiovascular risk factors, as well as specific genetic factors related to certain sleep disorders.

Durmaz AA, Karaca E, Demkow U, Toruner G, Schoumans J, Cogulu O. Evolution of genetic techniques: past, present, and beyond. BioMed Res Int. 2015. https://doi.org/10.1155/2015/461524.CrossRefPubMedPubMedCentral

Erhart G, Lamina C, Lehtimäki T, et al. Genetic factors explain a major fraction of the 50% lower lipoprotein(a) concentrations in Finns. Arterioscler Thromb Vasc Biol. 2018;38(5):1230–41. https://doi.org/10.1161/ATVBAHA.118.310865.CrossRefPubMedPubMedCentral

NINDS Stroke Genetics Network (SiGN) and International Stroke Genetics Consortium. Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study. Lancet Global Health. 2015;4422(15):4–7. https://doi.org/10.1016/S1474-4422(15)00338-5.CrossRef

Traylor M, Farrall M, Holliday EG, et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol. 2012;11(11):951–62. https://doi.org/10.1016/S1474-4422(12)70234-X.CrossRefPubMedPubMedCentral

Pulit SL, McArdle PF, Wong Q, et al. The NINDS Stroke Genetics Network: a genome-wide association study of ischemic stroke and its subtypes. Lancet Neurol. 2016;15(2):174–84. https://doi.org/10.1016/S1474-4422(15)00338-5.The.CrossRef

Cai H, Liang J, Liu Z, et al. Causal effects of sleep traits on ischemic stroke and its subtypes: a Mendelian randomization study. Nat Sci Sleep. 2020;12:783–90. https://doi.org/10.2147/NSS.S265946.CrossRefPubMedPubMedCentral

Lu H, Wu PF, Li RZ, Zhang W, Huang GX. Sleep duration and stroke: a Mendelian randomization study. Front Neurol. 2020;11(October):1–6. https://doi.org/10.3389/fneur.2020.00976.CrossRef

Duan R, Liu X, Wang T, Wu L, Gao X, Zhang Z. Histone acetylation regulation in sleep deprivation-induced spatial memory impairment. Neurochem Res. 2016;41(9):2223–32. https://doi.org/10.1007/s11064-016-1937-6.CrossRefPubMed

Zheng Q, Ma Y, Chen S, Che Q, Zhou Z, Chen D. Identification of genetic loci jointly influencing coronary artery disease risk and sleep traits of insomnia, sleep duration, and chronotype. Sleep Med. 2020;74:116–23. https://doi.org/10.1016/j.sleep.2020.06.027.CrossRefPubMed

10.

Foo JC, Trautmann N, Sticht C, et al. Longitudinal transcriptome-wide gene expression analysis of sleep deprivation treatment shows involvement of circadian genes and immune pathways. Transl Psychiatry. 2019. https://doi.org/10.1038/s41398-019-0671-7.CrossRefPubMedPubMedCentral

11.

Sandford AJ, Ha A, Ngan DA, et al. Adhesion molecule gene variants and plasma protein levels in patients with suspected obstructive sleep apnea. PLoS ONE. 2019;14(1):1–12. https://doi.org/10.1371/journal.pone.0210732.CrossRef

12.

Zhao W, Yuan T, Fu Y, et al. Seasonal differences in the transcriptome profile of the Zhedong white goose (Anser cygnoides) pituitary gland. Poult Sci. 2021;100(2):1154–66. https://doi.org/10.1016/j.psj.2020.10.049.CrossRefPubMed

13.

Reis LM, Tyler RC, Volkmann Kloss BA, et al. PITX2 and FOXC1 spectrum of mutations in ocular syndromes. Eur J Hum Genet. 2012;20(12):1224–33. https://doi.org/10.1038/ejhg.2012.80.CrossRefPubMedPubMedCentral

14.

Milićević N, Duursma A, ten Asbroek ALMA, Felder-Schmittbuhl MP, Bergen AA. Does the circadian clock make RPE-mediated ion transport “tick” via SLC12A2 (NKCC1)? Chronobiol Int. 2019;36(11):1592–8. https://doi.org/10.1080/07420528.2019.1653317.CrossRefPubMed

15.

Chauhan G, Arnold CR, Chu AY, et al. Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2016;15(7):695–707. https://doi.org/10.1016/S1474-4422(16)00102-2.CrossRef

16.

Lane JM, Liang J, Vlasac I, et al. Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits. Nat Genet. 2017;49(2):274–81. https://doi.org/10.1038/ng.3749.CrossRefPubMed

17.

Traylor M, Andreson C, Rutten-Jacobs LCA, et al. The subtype specificity of genetic loci associated with stroke in 16,664 cases and 32,792 controls. Circ Genom Precis Med. 2019;12(7): e002338. https://doi.org/10.1161/CIRCGEN.118.002338.The.CrossRefPubMedPubMedCentral

18.

Buck D, Diefenbach K, Penzel T, Malzahn U, Roots I, Fietze I. Genetic polymorphisms in endothelin-receptor-subtype-a-gene as susceptibility factor for obstructive sleep apnea syndrome. Sleep Med. 2010;11(2):213–7. https://doi.org/10.1016/j.sleep.2009.06.009.CrossRefPubMed

19.

Chatsuriyawong S, Gozal D, Kheirandish-Gozal L, et al. Polymorphisms in nitric oxide synthase and endothelin genes among children with obstructive sleep apnea. BMC Med Genom. 2013;6(1):1. https://doi.org/10.1186/1755-8794-6-29.CrossRef

20.

Krohn M, Bracke A, Avchalumov Y, et al. Accumulation of murine amyloid-β mimics early Alzheimer’s disease. Brain. 2015;138(8):2370–82. https://doi.org/10.1093/brain/awv137.CrossRefPubMed

21.

Nishiyama T, Nakatochi M, Goto A, et al. Genome-wide association meta-analysis and Mendelian randomization analysis confirm the influence of ALDH2 on sleep duration in the Japanese population. Sleep. 2019;42(6):1–11. https://doi.org/10.1093/sleep/zsz046.CrossRef

22.

Lin CY, Yu RL, Wu RM, Tan CH. Effect of ALDH2 on sleep disturbances in patients with Parkinson’s disease. Sci Rep. 2019;9(1):1–8. https://doi.org/10.1038/s41598-019-55427-w.CrossRef

23.

Lahtinen A, Puttonen S, Vanttola P, et al. A distinctive DNA methylation pattern in insufficient sleep. Sci Rep. 2019;9(1):1–9. https://doi.org/10.1038/s41598-018-38009-0.CrossRef

24.

Fu X-J, Li H-X, Yang K, Chen D, Tang H. The important tumor suppressor role of PER1 in regulating the cyclin–cDK–cKi network in scc15 human oral squamous cell carcinoma cells. Oncol Targets Ther. 2016;9:2237–45.

25.

Bouchard-Cannon P, Mendoza-Viveros L, Yuen A, Kærn M, Cheng HYM. The circadian molecular clock regulates adult hippocampal neurogenesis by controlling the timing of cell-cycle entry and exit. Cell Rep. 2013;5(4):961–73. https://doi.org/10.1016/j.celrep.2013.10.037.CrossRefPubMed

26.

Fan M, Sun D, Zhou T, et al. Sleep patterns, genetic susceptibility, and incident cardiovascular disease: a prospective study of 385,292 UK biobank participants. Eur Heart J. 2020;41(11):1182–9. https://doi.org/10.1093/eurheartj/ehz849.CrossRefPubMed

27.

Krittanawong C, Tunhasiriwet A, Wang Z, et al. Association between short and long sleep durations and cardiovascular outcomes: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care. 2019;8(8):762–70. https://doi.org/10.1177/2048872617741733.CrossRefPubMed

28.

Cai H, Shu XO, Xiang YB, et al. Sleep duration and mortality: a prospective study of 113,138 middle-aged and elderly Chinese men and women. Sleep. 2015;38(4):529–36. https://doi.org/10.5665/sleep.4564.CrossRefPubMedPubMedCentral

29.

Jin X, Pan B, Dang X, Wu H, Xu D. Relationship between short telomere length and stroke: a meta-analysis. Medicine (Baltimore). 2018;97(39):e12489. https://doi.org/10.1097/MD.0000000000012489.CrossRef

30.

James S, McLanahan S, Brooks-Gunn J, et al. Sleep duration and telomere length in children. J Pediatr. 2017;187:247–52. https://doi.org/10.1016/j.jpeds.2017.05.014.Sleep.CrossRefPubMedPubMedCentral

31.

Heath AC, Kendler KS, Eaves LJ, Martin NG. Evidence for genetic influences on sleep disturbance and sleep pattern in twins. Sleep. 1990;13(4):318–35. https://doi.org/10.1093/sleep/13.4.318.CrossRefPubMed

32.

Jones SE, van Hees VT, Mazzotti DR, et al. Genetic studies of accelerometer-based sleep measures yield new insights into human sleep behaviour. Nat Commun. 2019;10(1):1–12. https://doi.org/10.1038/s41467-019-09576-1.CrossRef

33.

Morselli LL, Gamazon ER, Tasali E, Cox NJ, Van Cauter E, Davis LK. Shared genetic control of brain activity during sleep and insulin secretion: a laboratory-based family study. Diabetes. 2018;67(1):155–64. https://doi.org/10.2337/db16-1229.CrossRefPubMed

34.

Dashti HS, Jones SE, Wood AR, et al. Genome-wide association study identifies genetic loci for self-reported habitual sleep duration supported by accelerometer-derived estimates. Nat Commun. 2019;10(1):1–12. https://doi.org/10.1038/s41467-019-08917-4.CrossRef

35.

Nesbitt AL, Lim ZLT, Chan KJ, Zardawi I, Pridgeon SW. Metastatic renal cell carcinoma presenting with both acute stroke and an oral lesion. Urol Case Rep. 2018;2019(23):75–7. https://doi.org/10.1016/j.eucr.2019.01.010.CrossRef

36.

Prayson RA. Metastatic chromophobe renal cell carcinoma to the brain. J Clin Neurosci. 2016;26:152–3. https://doi.org/10.1016/j.jocn.2015.10.007.CrossRefPubMed

37.

Jang AI, Bernstock JD, Segar DJ, Distasio M, Matulonis U, Bi WL. Case report: frontoparietal metastasis from a primary fallopian tube carcinoma. Front Surg. 2021;8(February):1–6. https://doi.org/10.3389/fsurg.2021.594570.CrossRef

38.

Manfredini R, Boari B, Smolensky M, et al. Circadian variation in stroke onset: identical temporal pattern in ischemic and hemorrhagic events. Chronobiol Int. 2005;22(3):417–53. https://doi.org/10.1081/CBI-200062927.CrossRefPubMed

39.

Lincoln GA, Clarke IJ, Hut RAHD. Characterizing a mammalian circannual pacemaker. Science. 2006;314:1941–4.CrossRef

40.

Christou S, Wehrens SMT, Isherwood C, et al. Circadian regulation in human white adipose tissue revealed by transcriptome and metabolic network analysis. Sci Rep. 2019;9(1):1–12. https://doi.org/10.1038/s41598-019-39668-3.CrossRef

41.

Takeda N, Maemura K. The role of clock genes and circadian rhythm in the development of cardiovascular diseases. Cell Mol Life Sci. 2015. https://doi.org/10.1007/s00018-015-1923-1.CrossRefPubMed

42.

Iii EM, Adams HP, Marler JR, Hulbert JR, Love BB, Gordon DL. Circadian variation in onset of acute ischemic stroke. Arch Neurol. 1990;47:1178–80.CrossRef

43.

Zhuang Z, Gao M, Yang R, et al. Association of physical activity, sedentary behaviours and sleep duration with cardiovascular diseases and lipid profiles: a Mendelian randomization analysis. Lipids Health Dis. 2020;19(1):1–11. https://doi.org/10.1186/s12944-020-01257-z.CrossRef

44.

Hughes ME, Abruzzi KC, Allada R, et al. Guidelines for genome-scale analysis of biological rhythms. J Biol Rhythms. 2017;32(5):380–93. https://doi.org/10.1177/0748730417728663.CrossRefPubMedPubMedCentral

45.

Riestra P, Gebreab SY, Xu R, et al. Circadian CLOCK gene polymorphisms in relation to sleep patterns and obesity in African Americans: findings from the Jackson heart study. BMC Genet. 2017;18(1):1–10. https://doi.org/10.1186/s12863-017-0522-6.CrossRef

46.

Corella D, Asensio EM, Coltell O, et al. CLOCK gene variation is associated with incidence of type-2 diabetes and cardiovascular diseases in type-2 diabetic subjects: dietary modulation in the PREDIMED randomized trial. Cardiovasc Diabetol. 2016;15(1):1–12. https://doi.org/10.1186/s12933-015-0327-8.CrossRef

47.

Jones SE, Lane JM, Wood AR, et al. Genome-wide association analyses of chronotype in 697,828 individuals provides insights into circadian rhythms. Nat Commun. 2019. https://doi.org/10.1038/s41467-018-08259-7.CrossRefPubMedPubMedCentral

48.

Veatch OJ, Keenan BT, Gehrman PR, Malow BA, Pack AI. Pleiotropic genetic effects influencing sleep and neurological disorders. Lancet Neurol. 2017;16(2):158–70. https://doi.org/10.1016/S1474-4422(16)30339-8.CrossRefPubMedPubMedCentral

49.

Beker MC, Caglayan B, Yalcin E, et al. Time-of-day-dependent neuronal injury after ischemic stroke: implication of circadian clock transcriptional factor bmal1 and survival kinase AKT. Mol Neurobiol. 2018;55(3):2565–76. https://doi.org/10.1007/s12035-017-0524-4.CrossRefPubMed

50.

Schallner N, Lieberum J-L, Gallo D, et al. Carbon monoxide preserves circadian rhythm to reduce the severity of subarachnoid hemorrhage in mice. Stroke. 2017;48(9):2565–73. https://doi.org/10.1161/STROKEAHA.116.016165.Carbon.CrossRefPubMedPubMedCentral

51.

Lembach A, Stahr A, Ali AAH, Ingenwerth M, von Gall C. Sex-dependent effects of bmal1-deficiency on mouse cerebral cortex infarction in response to photothrombotic stroke. Int J Mol Sci. 2018;19(10):1–16. https://doi.org/10.3390/ijms19103124.CrossRef

52.

Boden MJ, Varcoe TJ, Voultsios A, Kennaway DJ. Reproductive biology of female Bmal1 null mice. Reproduction. 2010;139(6):1077–90. https://doi.org/10.1530/REP-09-0523.CrossRefPubMed

53.

Tischkau SA, Cohen JA, Stark JT, Gross DR, Bottum KM. Time-of-day affects expression of hippocampal markers for ischemic damage induced by global ischemia. Exp Neurol. 2007;208(2):314–22. https://doi.org/10.1016/j.expneurol.2007.09.003.CrossRefPubMed

54.

Correa-Costa M, Gallo D, Csizmadia E, et al. Carbon monoxide protects the kidney through the central circadian clock and CD39. Proc Natl Acad Sci USA. 2018;115(10):E2302–10. https://doi.org/10.1073/pnas.1716747115.CrossRefPubMedPubMedCentral

55.

Cain SW, Chang A, Vlasac I, et al. Circadian rhythms in plasma brain-derived neurotrophic factor differ in men and women. J Biol Rhythms. 2017;32(1):75–82. https://doi.org/10.1177/0748730417693124.CrossRefPubMed

56.

Liang F, Walline R, Earnest DJ. Circadian rhythm of brain-derived neurotrophic factor in the rat suprachiasmatic nucleus. Neurosci Lett. 1998;242:89–92.CrossRef

57.

Girardet C, Lebrun B, Cabirol-Pol M-J, et al. Brain-derived neurotrophic factor/TrkB signaling regulates daily astroglial plasticity in the suprachiasmatic nucleus: electron-microscopic evidence in mouse. Glia. 2013;61:1172–7. https://doi.org/10.1002/glia.22509.CrossRefPubMed

58.

Xie H, Yung WH. Chronic intermittent hypoxia-induced deficits in synaptic plasticity and neurocognitive functions: a role for brain-derived neurotrophic factor. Acta Pharmacol Sin. 2012;33(1):5–10. https://doi.org/10.1038/aps.2011.184.CrossRefPubMedPubMedCentral

59.

Flores KR, Viccaro F, Aquilini M, et al. Protective role of brain derived neurotrophic factor (BDNF) in obstructive sleep apnea syndrome (OSAS) patients. PLoS ONE. 2020;15(1):1–11. https://doi.org/10.1371/journal.pone.0227834.CrossRef

60.

Schmitt K, Holsboer-Trachsler E, Eckert A. BDNF in sleep, insomnia, and sleep deprivation. Ann Med. 2016;48(1–2):42–51. https://doi.org/10.3109/07853890.2015.1131327.CrossRefPubMed

61.

Duez H, Staels B. The nuclear receptors Rev-erbs and RORs integrate circadian rhythms and metabolism. Diab Vasc Dis Res. 2008;5(2):82–8. https://doi.org/10.3132/dvdr.2008.0014.CrossRefPubMed

62.

Sengupta S, Yang G, Donnell JCO, et al. The circadian gene Rev-erbα improves cellular bioenergetics and provides preconditioning for protection against oxidative stress. Free Radic Biol Med. 2016;93:177–89. https://doi.org/10.1016/j.freeradbiomed.2016.02.004.The.CrossRefPubMedPubMedCentral

63.

Wolff SEC, Wang XL, Jiao H, et al. The effect of Rev-erbα agonist SR9011 on the immune response and cell metabolism of microglia. Front Immunol. 2020. https://doi.org/10.3389/fimmu.2020.550145.CrossRefPubMedPubMedCentral

64.

Zang M, Zhao Y, Gao L, et al. The circadian nuclear receptor RORα negatively regulates cerebral ischemia-reperfusion injury and mediates the neuroprotective effects of melatonin. BBA Mol Basis Dis. 2020. https://doi.org/10.1016/j.bbadis.2020.165890.CrossRef

65.

Chern CM, Liao JF, Wang YH, Shen YC. Melatonin ameliorates neural function by promoting endogenous neurogenesis through the MT2 melatonin receptor in ischemic-stroke mice. Free Radical Biol Med. 2012;52(9):1634–47. https://doi.org/10.1016/j.freeradbiomed.2012.01.030.CrossRef

66.

Andersson EA, Holst B, Sparsø T, et al. MTNR1B G24E variant associates with BMI and fasting plasma glucose in the general population in studies of 22,142 Europeans. Diabetes. 2010;59(June):1539–48. https://doi.org/10.2337/db09-1757.CrossRefPubMedPubMedCentral

67.

Sparsø T, Andersson E, Bouatia-naji N, et al. G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19605 Europeans. Diabetes. 2009;58(June):1450–6. https://doi.org/10.2337/db08-1660.T.S.CrossRefPubMedPubMedCentral

68.

Wilcox AG, Vizor L, Parsons MJ, Banks G, Nolan PM. Inducible knockout of mouse Zfhx3 emphasizes its key role in setting the pace and amplitude of the adult circadian clock. J Biol Rhythms. 2017;32(5):433–43. https://doi.org/10.1177/0748730417722631.CrossRefPubMedPubMedCentral

69.

Balzani E, Lassi G, Maggi S, et al. The Zfhx3-mediated axis regulates sleep and interval timing in mice. Cell Rep. 2016;16(3):615–21. https://doi.org/10.1016/j.celrep.2016.06.017.The.CrossRefPubMedPubMedCentral

70.

Lee C, Wallingford JB, Gross JM, Gross J. Cluap1 is essential for ciliogenesis and photoreceptor maintenance in the vertebrate eye. Investig Opthalmol Vis Sci. 2014;55(7):4585.CrossRef

71.

Zhong X, Li JQ, Sun L, et al. A Genome-wide association study of α-synuclein levels in cerebrospinal fluid. Neurotox Res. 2019;35(1):41–8. https://doi.org/10.1007/s12640-018-9922-2.CrossRefPubMed

72.

Falup-Pecurariu C, Diaconu S, Tînt D, Falup-Pecurariu O. Neurobiology of sleep (review). Exp Ther Med. 2021;21(3):1–4. https://doi.org/10.3892/etm.2021.9703.CrossRef

73.

Ito M, Aswendt M, Lee AG, Ishizaka S, Cao Z, Wang EH, et al. RNA sequencing analysis revealed a distinct motor cortex transcriptome in spontaneously-recovered mice after stroke Masaki. Stroke. 2018;49(9):2191–9. https://doi.org/10.1161/STROKEAHA.118.021508.RNA.CrossRefPubMedPubMedCentral

74.

Qiu J, Yan Z, Tao K, et al. Sinomenine activates astrocytic dopamine D2 receptors and alleviates neuroinflammatory injury via the CRYAB/STAT3 pathway after ischemic stroke in mice. J Neuroinflammation. 2016;13(1):1–13. https://doi.org/10.1186/s12974-016-0739-8.CrossRef

75.

Hood S, Cassidy P, Cossette MP, et al. Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. J Neurosci. 2010;30(42):14046–58. https://doi.org/10.1523/JNEUROSCI.2128-10.2010.CrossRefPubMedPubMedCentral

76.

Cade BE, Gottlieb DJ, Lauderdale DS, et al. Common variants in DRD2 are associated with sleep duration: the CARe Consortium. Hum Mol Genet. 2015;25(1):167–79.CrossRef

77.

Rhodes JA, Lane JM, Vlasac IM, Rutter MK, Czeisler CA, Saxena R. Association of DAT1 genetic variants with habitual sleep duration in the UK Biobank. Sleep. 2019;42(1):1–6. https://doi.org/10.1093/sleep/zsy193.CrossRef

78.

Valomon A, Holst SC, Bachmann V, et al. Genetic polymorphisms of DAT1 and COMT differentially associate with actigraphy-derived sleep-wake cycles in young adults. Chronobiol Int. 2014;31(5):705–14. https://doi.org/10.3109/07420528.2014.896376.CrossRefPubMed

79.

Holst SC, Müller T, Valomon A, Seebauer B, Berger W, Landolt HP. Functional Polymorphisms in dopaminergic genes modulate neurobehavioral and neurophysiological consequences of sleep deprivation. Sci Rep. 2017;7(April):1–11. https://doi.org/10.1038/srep45982.CrossRef

80.

Holst SC, Bersagliere A, Bachmann V, Berger W, Achermann P, Landolt HP. Dopaminergic role in regulating neurophysiological markers of sleep homeostasis in humans. J Neurosci. 2014;34(2):566–73. https://doi.org/10.1523/JNEUROSCI.4128-13.2014.CrossRefPubMedPubMedCentral

81.

Jiang Y, Liu B, Wu C, et al. Dopamine receptor d2 gene (Drd2) polymorphisms, job stress, and their interaction on sleep dysfunction. Int J Environ Res Public Health. 2020;17(21):1–11. https://doi.org/10.3390/ijerph17218174.CrossRef

82.

Vandenbergh DJ, O’Connor RJ, Grant MD, et al. Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors. Addict Biol. 2007;12(1):106–16. https://doi.org/10.1111/j.1369-1600.2007.00054.x.CrossRefPubMed

83.

Chan T, Bates J, Lansford J, et al. Impulsivity and genetic variants in DRD2 and ANKK1 moderate longitudinal associations between sleep problems and overweight from ages 5 to 11. Int J Obes (Lond). 2014;38(3):404–10. https://doi.org/10.1038/ijo.2013.123.Impulsivity.CrossRef

84.

Noble EP, Noble RE, Ritchie T, et al. D2 dopamine receptor gene and obesity. Int J Eat Disord. 1994;15(3):205–17. https://doi.org/10.1002/1098-108X(199404)15:3%3c205::AID-EAT2260150303%3e3.0.CO;2-P.CrossRefPubMed

85.

Oporto GH, Bornhardt T, Iturriaga V, Salazar LA. Single nucleotide polymorphisms in genes of dopaminergic pathways are associated with bruxism. Clin Oral Invest. 2018;22(1):331–7. https://doi.org/10.1007/s00784-017-2117-z.CrossRef

86.

Yi HS, Kim HS, Seo MR. Trial of oral metoclopramide on diurnal bruxism of brain injury. Ann Rehabil Med. 2013;37(6):871–4. https://doi.org/10.5535/arm.2013.37.6.871.CrossRefPubMedPubMedCentral

87.

Xu H, Guan J, Yi H, Yin S. A systematic review and meta-analysis of the association between serotonergic gene polymorphisms and obstructive sleep apnea syndrome. PLoS ONE. 2014;9(1):1–8. https://doi.org/10.1371/journal.pone.0086460.CrossRef

88.

Oporto GH, Bornhardt T, Iturriaga V, Salazar LA. Genetic polymorphisms in the serotonergic system are associated with circadian manifestations of bruxism. J Oral Rehabil. 2016;43(11):805–12. https://doi.org/10.1111/joor.12436.CrossRefPubMed

89.

Kim JM, Stewart R, Bae KY, et al. Serotonergic and BDNF genes and risk of depression after stroke. J Affect Disord. 2012;136(3):833–40. https://doi.org/10.1016/j.jad.2011.09.029.CrossRefPubMed

90.

Olesen OF, Bennike B, Dam H, Mellerup E. Association of the 5-HT2A receptor gene polymorphism 102T/C with ischemic stroke. J Mol Neurosci. 2006;30(3):323–8. https://doi.org/10.1385/JMN:30:3:323.CrossRefPubMed

91.

Bai X, Kirchhoff F, Scheller A. Oligodendroglial GABAergic signaling: more than inhibition! Neurosci Bull. 2021. https://doi.org/10.1007/s12264-021-00693-w.CrossRefPubMedPubMedCentral

92.

Okamura M, Inoue T, Takamatsu Y, Maejima H. Low-level inhibition of GABAergic synapses enhances gene expressions crucial for neuronal plasticity in the hippocampus after ischemic stroke. J Stroke Cerebrovasc Dis. 2020;29(12): 105316. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105316.CrossRefPubMed

93.

Müller HD, Neder A, Sommer C, Schäbitz WR. Different postischemic protein expression of the GABAA receptor α2 subunit and the plasticity-associated protein MAP1B after treatment with BDNF versus G-CSF in the rat brain. Restor Neurol Neurosci. 2009;27(1):27–39. https://doi.org/10.3233/RNN-2009-0459.CrossRefPubMed

94.

Gao J, Qin Z, Qu X, et al. Endogenous neuroprotective mechanism of ATP2B1 in transcriptional regulation of ischemic preconditioning. Am J Transl Res. 2021;13(3):1170–83.PubMedPubMedCentral

95.

Wang H, Lane JM, Jones SE, et al. Genome-wide association analysis of self-reported daytime sleepiness identifies 42 loci that suggest biological subtypes. Nat Commun. 2019;10(1):1–12. https://doi.org/10.1038/s41467-019-11456-7.CrossRef

96.

Xu X, Qu W, Bian M, Huang F, Fei J, Urade Y. Essential roles of GABA transporter-1 in controlling rapid eye movement sleep and in increased slow wave activity after sleep deprivation. PLoS ONE. 2013;8(10): e75823. https://doi.org/10.1371/journal.pone.0075823.CrossRefPubMedPubMedCentral

97.

Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain lulu. Science. 2014;342(6156):1–11. https://doi.org/10.1126/science.1241224.Sleep.CrossRef

98.

Kim Y-K, Nam KI, Song J. The glymphatic system in diabetes-induced dementia. Front Neurol. 2018;9(October):1–10. https://doi.org/10.3389/fneur.2018.00867.CrossRef

99.

Cam E, Gao B, Imbach L, Hodor A, Bassetti CL. Sleep deprivation before stroke is neuroprotective: a pre-ischemic conditioning related to sleep rebound. Exp Neurol. 2013;247:673–9. https://doi.org/10.1016/j.expneurol.2013.03.003.CrossRefPubMed

100.

Moldovan M, Constantinescu AO, Balseanu A, Oprescu N, Zagrean L, Popa-Wagner A. Sleep deprivation attenuates experimental stroke severity in rats. Exp Neurol. 2010;222(1):135–43. https://doi.org/10.1016/j.expneurol.2009.12.023.CrossRefPubMed

101.

Pace M, Adamantidis A, Facchin L, Bassetti C. Role of REM sleep, melanin concentrating hormone and orexin/hypocretin systems in the sleep deprivation pre-ischemia. PLoS ONE. 2017;12(1):1–22. https://doi.org/10.1371/journal.pone.0168430.CrossRef

102.

Jaskova K, Pavlovicova M, Jurkovicova D. Electrophysiological variability in the SH-SY5Y cellular line. Gen Physiol Biophys. 2014;31(4):375–82. https://doi.org/10.4149/gpb.CrossRef

103.

Berteotti C, Liguori C, Pace M. Dysregulation of the orexin/hypocretin system is not limited to narcolepsy but has far-reaching implications for neurological disorders. Eur J Neurosci. 2021;53(4):1136–54. https://doi.org/10.1111/ejn.15077.CrossRefPubMed

104.

Beuckmann CT, Sinton CM, Williams SC, et al. Expression of a poly-glutamine-Ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci. 2004;24(18):4469–77. https://doi.org/10.1523/JNEUROSCI.5560-03.2004.CrossRefPubMedPubMedCentral

105.

Hara J, Beuckmann CT, Nambu T, et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron. 2001;30(2):345–54. https://doi.org/10.1016/S0896-6273(01)00293-8.CrossRefPubMed

106.

Xiong X, White RE, Xu L, et al. Mitigation of murine focal cerebral ischemia by the hypocretin/ orexin system is associated with reduced inflammation. Stroke. 2013;44(3):764–70. https://doi.org/10.1161/STROKEAHA.112.681700.Mitigation.CrossRefPubMedPubMedCentral

107.

Wei CJ, Li W, Chen JF. Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies. Biochim Biophys Acta. 2011;1808(5):1358–79. https://doi.org/10.1016/j.bbamem.2010.12.018.CrossRefPubMed

108.

Zhou Y, Zeng X, Li G, et al. Inactivation of endothelial adenosine A2A receptors protects mice from cerebral ischaemia-induced brain injury. Br J Pharmacol. 2019;176(13):2250–63. https://doi.org/10.1111/bph.14673.CrossRefPubMedPubMedCentral

109.

Ledent C, Vaugeoist JM, Schiffmann SN, et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A(2a) receptor. Nature. 1997;388(6643):674–8. https://doi.org/10.1038/41771.CrossRefPubMed

110.

Hohoff C, Mullings EL, Heatherley SV, et al. Adenosine A2A receptor gene: evidence for association of risk variants with panic disorder and anxious personality. J Psychiatr Res. 2010;44(14):930–7. https://doi.org/10.1016/j.jpsychires.2010.02.006.CrossRefPubMed

111.

Stanzione R, Di Angelantonio E, Evangelista A, et al. β2-adrenergic receptor gene polymorphisms and risk of ischemic stroke. Am J Hypertens. 2007;20(6):657–62. https://doi.org/10.1016/j.amjhyper.2007.01.006.CrossRefPubMed

112.

Schürks M, Kurth T, Ridker PM, Buring JE, Zee RYL. Association between polymorphisms in the β2-adrenergic receptor gene with myocardial infarction and ischaemic stroke in women. Thromb Haemost. 2009;101(2):351–8. https://doi.org/10.1160/TH08-05-0284.CrossRefPubMedPubMedCentral

113.

Kumar A, Prasad M, Kumar P, Yadav AK, Pandit AK, Kathuria P. Association between beta adrenergic receptor polymorphism and ischemic stroke: a meta-analysis. J Stroke. 2015;17(2):138–43. https://doi.org/10.5853/jos.2015.17.2.138.CrossRefPubMedPubMedCentral

114.

Vardeny O, Peppard PE, Finn LA, Faraco JH, Mignot E, Hla KM. β2 adrenergic receptor polymorphisms and nocturnal blood pressure dipping status in the Wisconsin Sleep Cohort Study. J Am Soc Hypertens. 2011;5(2):114–22. https://doi.org/10.1016/j.jash.2011.01.005.CrossRefPubMedPubMedCentral

115.

Proitsi P, Lupton MK, Reeves SJ, et al. Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia. Neurobiol Aging. 2012;33(4):791–803. https://doi.org/10.1016/j.neurobiolaging.2010.06.011.CrossRefPubMed

116.

Wang H, Noordam R, Cade BE, Schwander K, Thomas W. Multi-ancestry genome-wide gene-sleep interactions identify novel loci for blood pressure. Mol Psychiatry. 2021. https://doi.org/10.1038/s41380-021-01087-0.CrossRefPubMedPubMedCentral

117.

Ohlsson T, Lindgren A, Engström G, Jern C, Melander O. A stop-codon of the phosphodiesterase 11A gene is associated with elevated blood pressure and measures of obesity. J Hypertens. 2016;34(3):445–51. https://doi.org/10.1097/HJH.0000000000000821.CrossRefPubMed

118.

Noordam R, Bos MM, Wang H, et al. Multi-ancestry sleep-by-SNP interaction analysis in 126,926 individuals reveals lipid loci stratified by sleep duration. Nat Commun. 2019;10(1):1–13. https://doi.org/10.1038/s41467-019-12958-0.CrossRef

119.

Dashti HS, Follis JL, Smith CE, et al. Gene-environment interactions of circadian-related genes for cardiometabolic traits. Diabetes Care. 2015;38(8):1456–66. https://doi.org/10.2337/dc14-2709.CrossRefPubMedPubMedCentral

120.

Fallaize R, Carvalho-Wells AL, Tierney AC, et al. APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome. Sci Rep. 2017;7(1):1–10. https://doi.org/10.1038/s41598-017-05802-2.CrossRef

121.

Martínez-Martínez AB, Torres-Perez E, Devanney N, Del Moral R, Johnson LA, Arbones-Mainar JM. Beyond the CNS: the many peripheral roles of APOE. Neurobiol Dis. 2019;2020(138): 104809. https://doi.org/10.1016/j.nbd.2020.104809.CrossRef

122.

Yesavage JA, Friedman L, Kraemer H, et al. Sleep/wake disruption in Alzheimer’s disease: APOE status and longitudinal course. J Geriatr Psychiatry Neurol. 2004;17(1):20–4. https://doi.org/10.1177/0891988703261994.CrossRefPubMed

123.

Pellegrino R, Mazzotti DR, Guindalini C, Santos-Silva R, Bittencourt LRA, Tufik S. Apolipoprotein E polymorphisms and sleep quality in obstructive sleep apnea syndrome. Clin Chim Acta. 2011;412(23–24):2223–7. https://doi.org/10.1016/j.cca.2011.08.007.CrossRefPubMed

124.

Yang L, Ma L, Guo W, Fang Q, Lai X, Zhang X. Interaction of polymorphisms in APOA4-APOA5-ZPR1-BUD13 gene cluster and sleep duration on 5-year lipid changes in middle aged and older Chinese. Sleep. 2019;42(8):1–9. https://doi.org/10.1093/sleep/zsz115.CrossRef

125.

Hwang JY, Byun MS, Choe YM, et al. Moderating effect of APOE ∈4 on the relationship between sleep-wake cycle and brain β-amyloid. Neurology. 2018;90(13):e1167–73. https://doi.org/10.1212/WNL.0000000000005193.CrossRefPubMed

126.

Xue J, Zhou D, Poulsen O, et al. Intermittent hypoxia and hypercapnia accelerate atherosclerosis, partially via trimethylamine-oxide. Am J Respir Cell Mol Biol. 2017;57(5):581–8. https://doi.org/10.1165/rcmb.2017-0086OC.CrossRefPubMedPubMedCentral

127.

Maury E, Ramsey KM, Bass J. Circadian rhythms and metabolic syndrome: from experimental genetics to human disease. Circ Res2. 2010;106(3):447–62. https://doi.org/10.1161/CIRCRESAHA.109.208355.Circadian.CrossRef

128.

Gamble KL, Berry R, Frank SJ, Young ME. Circadian clock control of endocrine factors. Nat Rev Endocrinol. 2014;10(8):466–75. https://doi.org/10.1038/nrendo.2014.78.CrossRefPubMedPubMedCentral

129.

Guo L, Costanzo-Garvey DL, Smith DR, Neilsen BK, MacDonald RG, Lewis RE. Kinase Suppressor of Ras 2 (KSR2) expression in the brain regulates energy balance and glucose homeostasis. Mol Metab. 2017;6(2):194–205. https://doi.org/10.1016/j.molmet.2016.12.004.CrossRefPubMed

130.

Revelli JP, Smith D, Allen J, et al. Profound obesity secondary to hyperphagia in mice lacking kinase suppressor of ras 2. Obesity. 2011;19(5):1010–8. https://doi.org/10.1038/oby.2010.282.CrossRefPubMed

131.

Pearce LR, Atanassova N, Banton MC, et al. KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidation. Cell. 2013;155(4):765. https://doi.org/10.1016/j.cell.2013.09.058.CrossRefPubMedPubMedCentral

132.

Tekola-Ayele F, Doumatey AP, Shriner D, et al. Genome-wide association study identifies African-ancestry specific variants for metabolic syndrome. Mol Genet Metab. 2015;116(4):305–13. https://doi.org/10.1016/j.ymgme.2015.10.008.Genome-wide.CrossRefPubMedPubMedCentral

133.

Celis-Morales C, Lyall DM, Guo Y, et al. Sleep characteristics modify the association of genetic predisposition with obesity and anthropometric measurements in 119,679 UK Biobank participants. Am J Clin Nutr. 2017;105(4):980–90. https://doi.org/10.3945/ajcn.116.147231.CrossRefPubMed

134.

Dashti HS, Follis JL, Smith CE, et al. Habitual sleep duration is associated with BMI and macronutrient intake and may be modified by CLOCK genetic variants. Am J Clin Nutr. 2015;101(1):135–43. https://doi.org/10.3945/ajcn.114.095026.CrossRefPubMed

135.

Li G, Feng D, Wang Y, et al. Loss of Cardio-protective effects at the CDH13 locus due to gene-sleep interaction: the BCAMS Study. EBioMedicine. 2018;32:164–71. https://doi.org/10.1016/j.ebiom.2018.05.033.CrossRefPubMedPubMedCentral

136.

Chung CM, Lin TH, Chen JW, et al. A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. Diabetes. 2011;60(9):2417–23. https://doi.org/10.2337/db10-1321.CrossRefPubMedPubMedCentral

137.

Lin C, Tang X, Zhu Z, et al. The rhythmic expression of clock genes attenuated in human plaque-derived vascular smooth muscle cells. Lipids Health Dis. 2014;13(1):1–9. https://doi.org/10.1186/1476-511X-13-14.CrossRef

138.

Perisic L, Aldi S, Sun Y, et al. Gene expression signatures, pathways and networks in carotid atherosclerosis. J Intern Med. 2016;279(3):293–308. https://doi.org/10.1111/joim.12448.CrossRefPubMed

139.

Kaparianos A, Sampsonas F, Karkoulias K, Spiropoulos K. Obstructive sleep apnoea syndrome and genes. Neth J Med. 2006;64(8):280–9.PubMed

140.

Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;163(1):19–25. https://doi.org/10.1164/ajrccm.163.1.2001008.CrossRefPubMed

141.

Caples SM, Garcia-Touchard A, Somers VK. Sleep-disordered breathing and cardiovascular risk. Sleep. 2007;30(3):291–303.CrossRef

142.

Linz D, Woehrle H, Bitter T, et al. The importance of sleep-disordered breathing in cardiovascular disease. Clin Res Cardiol. 2015;104(9):705–18. https://doi.org/10.1007/s00392-015-0859-7.CrossRefPubMed

143.

Strausz S, Ruotsalainen S, Ollila HM, et al. Genetic analysis of obstructive sleep apnoea discovers a strong association with cardiometabolic health. Eur Respir J. 2021;57(5):2003091.CrossRef

144.

Parra O, Sánchez-Armengol A, Bonnin M, et al. Early treatment of obstructive apnoea and stroke outcome: a randomised controlled trial. Eur Respir J. 2011;37(5):1128–36. https://doi.org/10.1183/09031936.00034410.CrossRefPubMed

145.

Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke A. Stroke. 2019;50(12):E344–418. https://doi.org/10.1161/STR.0000000000000211.CrossRefPubMed

146.

Prabhakar NR, Semenza GL. Responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev. 2012;92(3):967–1003. https://doi.org/10.1152/physrev.00030.2011.ADAPTIVE.CrossRefPubMed

147.

Minegishi S, Sagami I, Negi S, Kano K, Kitagishi H. Circadian clock disruption by selective removal of endogenous carbon monoxide. Sci Rep. 2018;8(1):1–12. https://doi.org/10.1038/s41598-018-30425-6.CrossRef

148.

Sun Q, Zeng C, Du L, Dong C. Mechanism of circadian regulation of the NRF2/ARE pathway in renal ischemia-reperfusion. Exp Ther Med. 2021;21(3):1–9. https://doi.org/10.3892/etm.2021.9622.CrossRef

149.

Zhou L, Ouyang R, Luo H, et al. Dysfunction of Nrf2-ARE signaling pathway: potential pathogenesis in the development of neurocognitive impairment in patients with moderate to severe obstructive sleep apnea-hypopnea syndrome. Oxid Med Cell Longev. 2018. https://doi.org/10.1155/2018/3529709.CrossRefPubMedPubMedCentral

150.

Han Q, Yeung SC, Ip MSM, Mak JCW. Intermittent hypoxia-induced NF-κB and HO-1 regulation in human endothelial EA.hy926 Cells. Cell Biochem Biophys. 2013;66(3):431–41. https://doi.org/10.1007/s12013-012-9491-6.CrossRefPubMed

151.

Cao L, Zhang Z, Cai B, et al. Association of heme oxygenase-1 gene rs2071746 polymorphism with vascular outcomes in patients with atherosclerotic stroke. J Neurol Sci. 2014;344(1–2):154–7. https://doi.org/10.1016/j.jns.2014.06.046.CrossRefPubMed

152.

Oh J, Lee MS, Jeong JH, Lee M. Deoxycholic acid–conjugated polyethylenimine for delivery of heme oxygenase-1 gene in rat ischemic stroke model. J Pharm Sci. 2017;106(12):3524–32. https://doi.org/10.1016/j.xphs.2017.07.020.CrossRefPubMed

153.

Hyun H, Won YW, Kim KM, Lee J, Lee M, Kim YH. Therapeutic effects of a reducible poly (oligo-d-arginine) carrier with the heme oxygenase-1 gene in the treatment of hypoxic-ischemic brain injury. Biomaterials. 2010;31(34):9128–34. https://doi.org/10.1016/j.biomaterials.2010.08.038.CrossRefPubMed

154.

Hyun H, Lee J, Hwang DW, et al. Combinational therapy of ischemic brain stroke by delivery of heme oxygenase-1 gene and dexamethasone. Biomaterials. 2011;32(1):306–15. https://doi.org/10.1016/j.biomaterials.2010.08.116.CrossRefPubMed

155.

Lee Y, Lee J, Kim M, Kim GY, Choi JS, Lee M. Brain gene delivery using histidine and arginine-modified dendrimers for ischemic stroke therapy. J Control Release. 2021;330(October):907–19. https://doi.org/10.1016/j.jconrel.2020.10.064.CrossRefPubMed

156.

Oh J, Kim SM, Lee EH, et al. Messenger RNA/polymeric carrier nanoparticles for delivery of heme oxygenase-1 gene in the post-ischemic brain. Biomater Sci. 2020;8(11):3063–71. https://doi.org/10.1039/d0bm00076k.CrossRefPubMed

157.

Lavie L, Lotan R, Hochberg I, Herer P, Lavie P, Levy AP. Haptoglobin polymorphism is a risk factor for cardiovascular disease in patients with obstructive sleep apnea syndrome. Sleep. 2003;26(5):592–5. https://doi.org/10.1093/sleep/26.5.592.CrossRefPubMed

158.

Milman U, Blum S, Shapira C, et al. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2–2 genotype: a prospective double-blinded clinical trial. Arterioscler Thromb Vasc Biol. 2008;28(2):341–7. https://doi.org/10.1161/ATVBAHA.107.153965.CrossRefPubMed

159.

Staals J, Bons J, van Oostenbrugge R, et al. A SELDI-TOF-MS Study in Lacunar Stroke with Subsequent Haptoglobin Phenotyping. Curr Neurovasc Res. 2008;5(2):93–8. https://doi.org/10.2174/156720208784310187.CrossRefPubMed

160.

Staals J, Pieters B, Knottnerus I, et al. Haptoglobin polymorphism and lacunar stroke. Curr Neurovasc Res. 2008;5(3):153–8. https://doi.org/10.2174/156720208785425675.CrossRefPubMed

161.

Merkler A, Sertić J, Bazina Martinović A, et al. Haptoglobin genotype 2–2 associated with atherosclerosis in patients with ischemic stroke. Gene. 2020. https://doi.org/10.1016/j.gene.2020.144786.CrossRefPubMed

162.

Ijäs P, Saksi J, Soinne L, et al. Haptoglobin 2 allele associates with unstable carotid plaque and major cardiovascular events. Atherosclerosis. 2013;230(2):228–34. https://doi.org/10.1016/j.atherosclerosis.2013.07.008.CrossRefPubMed

163.

Bale BF, Doneen AL, Vigerust DJ. Precision healthcare of type 2 diabetic patients through implementation of haptoglobin genotyping. Front Cardiovasc Med. 2018;5(October):1–8. https://doi.org/10.3389/fcvm.2018.00141.CrossRef

164.

Belaidi E, Joyeux-Faure M, Ribuot C, Launois SH, Levy P, Godin-Ribuot D. Major Role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J Am Coll Cardiol. 2009;53(15):1309–17. https://doi.org/10.1016/j.jacc.2008.12.050.CrossRefPubMed

165.

Abeysinghe HCS, Bokhari L, Dusting GJ, Roulston CL. Brain remodelling following endothelin-1 induced stroke in conscious rats. PLoS ONE. 2014;9(5):1–14. https://doi.org/10.1371/journal.pone.0097007.CrossRef

166.

Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M. Increased plasma endothelin-1 in acute ischemic stroke. Stroke. 1992;23(7):1014–6. https://doi.org/10.1161/01.STR.23.7.1014.CrossRefPubMed

167.

Li J, Xu J, Liu Z, Zou Z, Jin M, Tao T. HIF-1α attenuates neuronal apoptosis by upregulating EPO expression following cerebral ischemia-reperfusion injury in a rat MCAO model. Int J Mol Med. 2020;45(4):1027–36. https://doi.org/10.3892/ijmm.2020.4480.CrossRefPubMedPubMedCentral

168.

Wakhloo D, Scharkowski F, Curto Y, et al. Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin. Nat Commun. 2020;11(1):1–12. https://doi.org/10.1038/s41467-020-15041-1.CrossRef

169.

Tani N, Ikeda T, Aoki Y, Shida A, Oritani S, Ishikawa T. Pathophysiological significance of clock genes BMAL1 and PER2 as erythropoietin-controlling factors in acute blood hemorrhage. Hum Cell. 2019. https://doi.org/10.1007/s13577-019-00248-2.CrossRefPubMed

170.

Mengozzi M, Cervellini I, Villa P, et al. Erythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental stroke. Proc Natl Acad Sci USA. 2012;109(24):9617–22. https://doi.org/10.1073/pnas.1200554109.CrossRefPubMedPubMedCentral

171.

Lam SY, Tipoe GL, Fung ML. Upregulation of erythropoietin and its receptor expression in the rat carotid body during chronic and intermittent hypoxia. Adv Exp Med Biol. 2009;648:207–14. https://doi.org/10.1007/978-90-481-2259-2_24.CrossRefPubMed

172.

Dayyat EA, Zhang SX, Wang Y, Cheng ZJ, Gozal D. Exogenous erythropoietin administration attenuates intermittent hypoxia-induced cognitive deficits in a murine model of sleep apnea. BMC Neurosci. 2012;13(1):1. https://doi.org/10.1186/1471-2202-13-77.CrossRef

173.

Chen Q, Lin G, Huang J, et al. Inhibition of miR-193a-3p protects human umbilical vein endothelial cells against intermittent hypoxia-induced endothelial injury by targeting FAIM2. Aging. 2020;12(2):1899–909. https://doi.org/10.18632/aging.102729.CrossRefPubMedPubMedCentral

174.

Komnig D, Gertz K, Habib P, et al. Faim2 contributes to neuroprotection by erythropoietin in transient brain ischemia. J Neurochem. 2018;145(3):258–70. https://doi.org/10.1111/jnc.14296.CrossRefPubMed

175.

Kendzerska T, Kamra M, Murray BJ, Boulos MI. Incident cardiovascular events and death in individuals with restless legs syndrome or periodic limb movements in sleep: a systematic review. Sleep. 2017;40(3):1–14. https://doi.org/10.1093/sleep/zsx013.CrossRef

176.

Cholley-Roulleau M, Chenini S, Béziat S, Guiraud L, Jaussent I, Dauvilliers Y. Restless legs syndrome and cardiovascular diseases: a case-control study. PLoS ONE. 2017;12(4):1–13. https://doi.org/10.1371/journal.pone.0176552.CrossRef

177.

Ferini-Strambi L, Walters AS, Sica D. The relationship among restless legs syndrome (Willis-Ekbom Disease), hypertension, cardiovascular disease, and cerebrovascular disease. J Neurol. 2014;261(6):1051–68. https://doi.org/10.1007/s00415-013-7065-1.CrossRefPubMed

178.

Gao X, Ba DM, Bagai K, Liu G, Ma C, Walters AS. Treating restless legs syndrome was associated with low risk of cardiovascular disease: a cohort study with 3.4 years of follow-up. J Am Heart Assoc. 2021;10(4):1–15. https://doi.org/10.1161/JAHA.120.018674.CrossRef

179.

Winkelman JW, Blackwell T, Stone K, Ancoli-Israel S, Redline S. Associations of Incident cardiovascular events with restless legs syndrome and periodic leg movements of sleep in older men, for the outcomes of sleep disorders in older men study (MrOS Sleep Study). Sleep. 2017;40(4):11. https://doi.org/10.1093/sleep/zsx023.CrossRef

180.

Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007;39(8):1000–6. https://doi.org/10.1038/ng2099.CrossRefPubMed

181.

Graff M, Scott RA, Justice AE, et al. Genome-wide physical activity interactions in adiposity—a meta-analysis of 200,452 adults. PLoS Genet. 2017;13(4):1–26. https://doi.org/10.1371/journal.pgen.1006528.CrossRef

182.

Bellei E, Bergamini S, Monari E, et al. Evaluation of potential cardiovascular risk protein biomarkers in high severity restless legs syndrome. J Neural Transm. 2019;126(10):1313–20. https://doi.org/10.1007/s00702-019-02051-7.CrossRefPubMed

183.

Bellei E, Monari E, Ozben S, et al. Discovery of restless legs syndrome plasmatic biomarkers by proteomic analysis. Brain Behavior. 2018;8(10):1–9. https://doi.org/10.1002/brb3.1062.CrossRef

184.

Hu Z, Liu J, Song Z, Hou Q, Fan X, Hou D. Variants in the atherogenic ALOX5AP, THBD, and KNG1 genes potentiate the risk of ischemic stroke via a genetic main effect and epistatic interactions in a Chinese population. J Stroke Cerebrovasc Dis. 2015;24(9):2060–8. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.04.036.CrossRefPubMed

185.

Rohmann JL, de Haan HG, Algra A, Vossen CY, Rosendaal FR, Siegerink B. Genetic determinants of activity and antigen levels of contact system factors. J Thromb Haemost. 2019;17(1):157–68. https://doi.org/10.1111/jth.14307.CrossRefPubMed

186.

Sabater-Lleal M, Martinez-Perez A, Buil A, et al. A genome-wide association study identifies KNG1 as a genetic determinant of plasma factor XI level and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol. 2012;32(8):2008–16. https://doi.org/10.1161/ATVBAHA.112.248492.CrossRefPubMed

187.

Mahta A, Yaghi S, Reznik ME, et al. Serum alpha-1 antitrypsin in acute ischemic stroke: a prospective pilot study. J Clin Neurosci. 2020;76:20–4. https://doi.org/10.1016/j.jocn.2020.04.074.CrossRefPubMed

188.

Wang T, Lu H, Li D, Huang W. Tgf-β1-mediated activation of serpine1 is involved in hemin-induced apoptotic and inflammatory injury in ht22 cells. Neuropsychiatr Dis Treat. 2021;17:423–33. https://doi.org/10.2147/NDT.S293772.CrossRefPubMedPubMedCentral

189.

Malik R, Dau T, Gonik M, et al. Common coding variant in SERPINA1 increases the risk for large artery stroke. Proc Natl Acad Sci USA. 2017;114(14):3613–8. https://doi.org/10.1073/pnas.1616301114.CrossRefPubMedPubMedCentral

190.

Liu Q, Cui P, Zheng K, et al. SERPINA1 gene expression in whole blood links the rs6647 variant G allele to an increased risk of large artery atherosclerotic stroke. FASEB J. 2020;34(8):10107–16. https://doi.org/10.1096/fj.201903197R.CrossRefPubMed

191.

Larsson SC, Markus HS. Genetic liability to insomnia and cardiovascular disease risk. Circulation. 2019;140(9):796–8. https://doi.org/10.1161/CIRCULATIONAHA.119.041830.CrossRefPubMed

192.

Parsa H, Imani A, Faghihi M, et al. Acute sleep deprivation preconditions the heart against ischemia/reperfusion injury: the role of central GABA-A receptors. Iran J Basic Med Sci. 2017;20:1232–41. https://doi.org/10.22038/IJBMS.2017.9539.CrossRefPubMedPubMedCentral

193.

Tao L, Wang L, Yang X, Jiang X, Hua F. Recombinant human glucagon-like peptide-1 protects against chronic intermittent hypoxia by improving myocardial energy metabolism and mitochondrial biogenesis. Mol Cell Endocrinol. 2018;2019(481):95–103. https://doi.org/10.1016/j.mce.2018.11.015.CrossRef

194.

Korkutata M, Saitoh T, Cherasse Y, et al. Enhancing endogenous adenosine A2A receptor signaling induces slow-wave sleep without affecting body temperature and cardiovascular function. Neuropharmacology. 2018;2019(144):122–32. https://doi.org/10.1016/j.neuropharm.2018.10.022.CrossRef

195.

Li Y, Perry TA, Kindy MS, et al. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc Natl Acad Sci USA. 2009;106(4):1285–90. https://doi.org/10.1073/pnas.0806720106.CrossRefPubMedPubMedCentral

196.

Fang X, Tong KZ, Wang X, Ni HF. Two mixed-ligand coordination polymers: Crystal structures and protective effect on ischemic stroke by increasing glp1r expression. J Oleo Sci. 2020;69(7):743–50. https://doi.org/10.5650/jos.ess20047.CrossRefPubMed

197.

Shinozuka K, Staples M, Borlongan CV. Melatonin-based therapeutics for neuroprotection in stroke. Int J Mol Sci. 2013;14(5):8924–47. https://doi.org/10.3390/ijms14058924.CrossRefPubMedPubMedCentral

198.

Rhim T, Lee DY, Lee M. Hypoxia as a target for tissue specific gene therapy. J Control Release. 2013;172(2):484–94. https://doi.org/10.1016/j.jconrel.2013.05.021.CrossRefPubMed

199.

Jiménez-Ortega V, Barquilla PC, Pagano ES, Fernández-Mateos P, Esquifino AI, Cardinali DP. Melatonin supplementation decreases prolactin synthesis and release in rat adenohypophysis: correlation with anterior pituitary redox state and circadian clock mechanisms. Chronobiol Int. 2012;29(8):1021–35. https://doi.org/10.3109/07420528.2012.705936.CrossRefPubMed

Title: Ischemic Stroke and Sleep: The Linking Genetic Factors
Author: Lyudmila Korostovtseva
Publication date: 01-12-2021
Publisher: Springer Healthcare
Keyword: Stroke
Published in: Cardiology and Therapy / Issue 2/2021
Print ISSN: 2193-8261
Electronic ISSN: 2193-6544
DOI: https://doi.org/10.1007/s40119-021-00231-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2021

Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?

Variations in Awareness of Association Between Adverse Pregnancy Outcomes and Cardiovascular Risk by Specialty

Thrombosis Prevention and Anticoagulation Management in the Pediatric Patient with Congenital Heart Disease

Effect of Amlodipine in Stroke and Myocardial infarction: A Systematic Review and Meta-analysis

Contemporary ICD Use in Patients with Heart Failure

Ablation Therapy as Management of Typical Atrial Flutter in the Early Period After Cardiac Surgery

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage